Front Row Series 2: Andy Beck on AI

In Part Two of this series on AI in Drug Discovery and Development, Andy Beck MD PhD, CEO and co-founder of Path AI, discusses the application of AI to a rare liver disease

0

In Part Two of this series on AI in Drug Discovery and Development, Andy Beck MD PhD, CEO and co-founder of Path AI, discusses the application of AI to a rare liver disease . . .

Get GEN Edge Today!

See More on the Edge

Continue reading this article and more
with a GEN Edge subscription

Start Your 30-Day Free Trial Now

Log In Join GEN Edge

Previous articleFront Row Series 2: Daphne Koller on AI
Next articleFront Row Series 2: AI in Drug Discovery and Development